Jiangsu Yanghe Distillery Co.,Ltd. (002304.SZ) reported its worst financial results since going public in 2025. Full-year revenue reached 19.211 billion yuan, a decrease of 33.47% compared to the previous year. Net profit attributable to shareholders plummeted by 66.94% to 2.206 billion yuan. Particularly concerning was the fourth-quarter performance, which showed a net loss of 1.769 billion yuan - an unusual occurrence for a leading baijiu producer.
The company's financial deterioration has been rapid. In 2023, net profit stood at 10.016 billion yuan, positioning Yanghe as the industry's third-largest player. This figure dropped to 6.673 billion yuan in 2024 before collapsing to just 2.206 billion yuan in 2025, effectively returning to 2010 levels. Market valuation reflected this decline, with shares falling from their 2021 peak of 249.55 yuan to approximately 50 yuan, erasing over 80% of market capitalization.
Several structural issues underlie this performance collapse. The company's distribution model, once a competitive advantage, has become a liability. Yanghe's sales expense ratio reached 19.1% in 2024, significantly higher than competitors like Kweichow Moutai (3.3%) and Wuliangye (around 11%). When revenue declined by over 30% in 2025, sales expenses decreased by only 5.63%, creating substantial profit pressure.
Product portfolio weaknesses have been equally damaging. Yanghe heavily depends on mid-range products like Haizhilane and Tianzhilan, with premium offerings accounting for less than 15% of revenue. This contrasts sharply with Moutai (over 85% premium) and Wuliangye (approximately 70%). The premium segment's vulnerability became apparent when Mengzhilan M9's market price fell to 895 yuan, 55% below its official 1,999 yuan guidance.
Inventory management represents another critical challenge. Year-end inventory value reached 20.375 billion yuan in 2025, exceeding annual revenue of 19.211 billion yuan. Inventory turnover days approached 900, meaning products remained in storage for nearly 2.5 years before sale. Distribution network erosion accelerated with 495 dealers exiting in 2025, including 429 from key non-local markets.
Cash flow deterioration added to concerns. Operating cash flow turned negative at -763 million yuan in 2025, compared to positive 4.629 billion yuan the previous year. Cash reserves declined by nearly 40% to 13.152 billion yuan. Capacity utilization fell to just 27%, with 72% of production capacity sitting idle.
Management changes accompanied these challenges. Former chairman Zhang Liandong, who took leadership in 2021 during industry peak, pursued aggressive expansion targets including doubling revenue to 50 billion yuan by 2025. Actual performance fell dramatically short, with 2025 revenue reaching only 19.211 billion yuan. Zhang resigned in 2025 after acknowledging management responsibility for the company's struggles.
New chairman Gu Yu, appointed in July 2025, implemented a contrasting strategy emphasizing inventory reduction, price stabilization, and market consolidation. However, first-quarter 2026 results showed continued pressure with revenue declining 26.03% and net profit falling 32.73% year-on-year.
The dividend policy controversy further damaged investor confidence. A promised minimum 7 billion yuan annual dividend for 2024-2026 was revised in 2026, removing the absolute amount guarantee while increasing the payout ratio to 100% of profits. The actual dividend consequently dropped by over 67% from previous commitments.
Competitive pressures intensified domestically, with Jiangsu competitor Jinshiyuan gaining ground in Yanghe's home market. Nationally, Yanghe's 19.2 billion yuan revenue barely exceeded Xijiu's 19 billion yuan, suggesting potential ranking changes among industry leaders.
While inventory levels showed some improvement in early 2026, with Haizhilane inventory reducing from 4-6 months to 2-2.5 months, fundamental demand recovery remains uncertain. The company faces the dual challenge of reversing its downward trajectory while addressing long-standing structural issues in distribution, product mix, and brand positioning.
Comments